Archives for April 20, 2015

Anti-fungal shows promise for cancer breakthrough in preclinical tests

An anti-fungal drug shows potential to treat a range of cancers, according to research from the Repurposing Drugs in Oncology (ReDO) project, but the drugmakers will need a financial incentive to pursue a licence for new indications.

Update

Teva bids $40bn for Mylan in proposed generics megamerger

A merger with Mylan would “transform the global generics space” says Teva, which has entered a $40bn bid as an alternative to the recently proposed Mylan-Perrigo deal.

US-Cuban embargo nears end as Pfizer and Regeneron make trade trip

Pfizer and Regeneron are in Cuba this week, scouting the country for business opportunities.

Update

US FDA to accept foreign trial data for approving medical devices

The FDA is releasing draft guidance articulating its current policy of accepting valid clinical data obtained from foreign clinical studies in support of premarket submissions for medical devices. 

Allergan axing a further 577 at Cali HQ, post-Actavis acquisition

Almost 600 staff at Allergan’s headquarters in Irvine, California, will be laid off in the Botox maker’s latest round of job cuts.